263 related articles for article (PubMed ID: 23768920)
1. Intraocular pressure monitoring post intravitreal steroids: a systematic review.
Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
Surv Ophthalmol; 2013; 58(4):291-310. PubMed ID: 23768920
[TBL] [Abstract][Full Text] [Related]
2. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
[No Abstract] [Full Text] [Related]
3. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
Kuley B; Storey PP; Pancholy M; Bello N; Murphy J; Goodman J; Wibbelsman TD; Obeid A; Chiang A; Regillo C; Garg S
Can J Ophthalmol; 2020 Dec; 55(6):480-485. PubMed ID: 32853591
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
6. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
Storey PP; Obeid A; Pancholy M; Goodman J; Borkar D; Su D; Regillo C
Retina; 2020 Jan; 40(1):75-79. PubMed ID: 30308561
[TBL] [Abstract][Full Text] [Related]
7. [Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015].
Dot C; El Chehab H; Russo A; Agard E
J Fr Ophtalmol; 2015 Sep; 38(7):656-64. PubMed ID: 26099427
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion.
Caillaux V; Valtot F; Souied EH; Mimoun G
Eur J Ophthalmol; 2015; 25(5):454-8. PubMed ID: 25743778
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Intraocular Pressure Increases and Management Strategies Following Treatment With Fluocinolone Acetonide Intravitreal Implants in the FAME Trials.
Parrish RK; Campochiaro PA; Pearson PA; Green K; Traverso CE;
Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):426-35. PubMed ID: 27183546
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
12. Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.
Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
Clin Exp Ophthalmol; 2015 Apr; 43(3):234-8. PubMed ID: 25214011
[TBL] [Abstract][Full Text] [Related]
13. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
[TBL] [Abstract][Full Text] [Related]
14. Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation.
Sadowsky AJ; Pecen PE; Feinstein E; Palestine AG
Ocul Immunol Inflamm; 2020 Jul; 28(5):828-832. PubMed ID: 31408390
[TBL] [Abstract][Full Text] [Related]
15. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
Mahar PS; Memon AS
J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
[TBL] [Abstract][Full Text] [Related]
18. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
[TBL] [Abstract][Full Text] [Related]
19. LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS: THE SAFODEX-2 STUDY.
Rezkallah A; Mathis T; Abukhashabah A; Voirin N; Malclès A; Agard É; Lereuil T; Denis P; Dot C; Kodjikian L
Retina; 2021 Jul; 41(7):1438-1445. PubMed ID: 33315814
[TBL] [Abstract][Full Text] [Related]
20. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
Yang CS; Chen MJ; Chou CK; Hsu WM
Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]